Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Mesh Bio raises US$1.8 million seed funding

Mesh Bio raises US$1.8 million seed funding
Share on FacebookShare on Twitter

Singapore-based healthtech start up Mesh bio has raised US$1.8 million (SG$2.4 million) in seed funding, led by deep tech investors Elev8.vc and enterprise Singapore’s investment arm Seeds Capital, along with Citrine Capital and Tael partners.

The funds will be used to accelerate the rollout of Mesh bio’s solution, DARA® – a predictive analytics and clinical workflow automation solution for healthcare providers – in Southeast Asia and Hong Kong. The funding will also support clinical partnerships and collaborations.

Mesh bio was founded in 2018 by healthcare and technology veterans – Andrew Wu, formerly Chief Operating Officer (COO) of Clearbridge Biomedics (now known as Biolidics), Arsen Batagov, former A*Star bioinformatics scientist and Dr Melvin Heng, physician and hospital administrator.

Andrew Wu, Mesh Bio Co-founder and CEO said, “Chronic diseases are increasing in Asia, making patient management increasingly complex and challenging. For instance, diabetes prevalence in Malaysia is the highest in Southeast Asia at 16.8 per cent. In Singapore it is 14.2 per cent and in Thailand, 8.3 per cent.

The situation is compounded by the lack of doctors, especially specialists, forcing general practitioners – lacking specialist training in endocrinology – to manage these challenging patient cases.

“Our vision is to deliver cutting-edge digital solutions to address challenges in patient management and rising chronic diseases in the region. Through the support of Elev8.vc, Seeds Capital, Citrine Capital and Tael partners, we see tremendous opportunity to help healthcare providers cope with the rise in cases and simultaneously, improve patient treatment and outcomes with DARA®,” he added.

DARA® Draws in real-time, multidimensional patient data: health history, lab tests and medical images. It delivers a patient-centric visual report, helping doctors counsel patients and allowing patients to understand their laboratory reports and the diseases they live with.

In-built with clinical best practices, guidelines and holistic patient assessments, DARA® helps doctors leverage knowledge from the global community of healthcare practitioners. Its risk assessment algorithms are compliant with local clinical practice guidelines.

DARA® has helped healthcare providers in Singapore analyse patient data quickly and effectively, increasing report generation by five times and reducing human error. The solution has delivered over 60 per cent in operational savings and 99 per cent in revenue growth.

Digital health technologies are increasingly in the spotlight since Covid-19, securing greater investor interest. In 2020, the Asia pacific digital health ecosystem closed US$ 6.14 billion in venture capital funding, 25 per cent higher than 2019. The top funded cluster was medical diagnostics.

Tags: analyticsForeign NewshealthtechThe Health ApriltheHealth
Previous Post

Healthcare firms’ security gaps

Next Post

True blue entrepreneur

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Painful urination: Early sepsis?
    September 30, 2021
    It is important to detect and treat urinary tract infection early to prevent it […]
  • Dr Rebecca among world’s top scientists
    March 1, 2021
    Dr Rebecca Wong Shin Yee, Associate Professor of Physiology and Head of […]
  • CRM achieves formation goals
    October 6, 2021
    Clinical Research Malaysia (CRM), a site management organisation owned by the […]
  • DKSH to distribute CanSino vaccine
    October 14, 2021
    DKSH Holdings (Malaysia) Berhad, the leading partner for companies seeking to […]
  • Musculoskeletal health and quality of life
    January 1, 2021
    BY 2040, the number of Malaysians aged 60 years and above is expected to double […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist